These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 10228759

  • 1. Increased blood proinsulin and decreased C-peptide levels in patients with pancreatic cancer.
    Nakamori S, Ishikawa O, Ohigashi H, Sasakuma F, Shimizu T, Nakaizumi A, Furukawa H, Sasaki Y, Imaoka S.
    Hepatogastroenterology; 1999; 46(25):16-24. PubMed ID: 10228759
    [Abstract] [Full Text] [Related]

  • 2. Diabetes mellitus in pancreatic cancer follow-up.
    Fogar P, Pasquali C, Basso D, Sperti C, Panozzo MP, Tessari G, D'Angeli F, Del Favero G, Plebani M.
    Anticancer Res; 1994; 14(6B):2827-30. PubMed ID: 7532931
    [Abstract] [Full Text] [Related]

  • 3. Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders.
    Tura A, Pacini G, Kautzky-Willer A, Ludvik B, Prager R, Thomaseth K.
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E155-62. PubMed ID: 12670835
    [Abstract] [Full Text] [Related]

  • 4. Proinsulin, insulin, and C-peptide in cystic fibrosis after an oral glucose tolerance test.
    Hartling SG, Garne S, Binder C, Heilmann C, Petersen W, Petersen KE, Koch C.
    Diabetes Res; 1988 Apr; 7(4):165-9. PubMed ID: 3042255
    [Abstract] [Full Text] [Related]

  • 5. Impaired glucose metabolism in colorectal cancer.
    Ehrmann-Jósko A, Siemińska J, Górnicka B, Ziarkiewicz-Wróblewska B, Ziółkowski B, Muszyński J.
    Scand J Gastroenterol; 2006 Sep; 41(9):1079-86. PubMed ID: 16938722
    [Abstract] [Full Text] [Related]

  • 6. Impaired proinsulin secretion before and during oral glucose stimulation in HIV-infected patients who display fat redistribution.
    Haugaard SB, Andersen O, Halsall I, Iversen J, Hales CN, Madsbad S.
    Metabolism; 2007 Jul; 56(7):939-46. PubMed ID: 17570256
    [Abstract] [Full Text] [Related]

  • 7. Plasma glucose, insulin, proinsulin, C-peptide and glucagon before and after a carbohydrate-rich meal in hyperthyroid patients.
    Rovira A, Valdivielso L, Ortega R, Valverde I, Herrera Pombo JL.
    Diabete Metab; 1987 Jul; 13(4):431-5. PubMed ID: 3315763
    [Abstract] [Full Text] [Related]

  • 8. Plasma insulin and C-peptide responses to oral glucose load after physical exercise in men with normal and impaired glucose tolerance.
    Nazar K, Kaciuba-Uściłko H, Chwalbińska-Moneta J, Krotkiewski M, Bicz B.
    Acta Physiol Pol; 1987 Jul; 38(6):458-66. PubMed ID: 3331233
    [Abstract] [Full Text] [Related]

  • 9. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
    Rosenfalck AM, Fisker S, Hilsted J, Dinesen B, Vølund A, Jørgensen JO, Christiansen JS, Madsbad S.
    Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
    [Abstract] [Full Text] [Related]

  • 10. Studies of the Ala/Val98 polymorphism of the hepatocyte nuclear factor-1alpha gene and the relationship to beta-cell function during an OGTT in glucose-tolerant women with and without previous gestational diabetes mellitus.
    Lauenborg J, Damm P, Ek J, Glümer C, Jørgensen T, Borch-Johnsen K, Vestergaard H, Hornnes P, Pedersen O, Hansen T.
    Diabet Med; 2004 Dec; 21(12):1310-5. PubMed ID: 15569134
    [Abstract] [Full Text] [Related]

  • 11. [Usefulness of oral glucose tolerance test (OGTT) in output patients with advanced chronic renal failure (CRF)].
    Rufino M, Barbero P, Hernández D, Torres A, Lorenzo V.
    Nefrologia; 2007 Dec; 27(1):30-7. PubMed ID: 17402877
    [Abstract] [Full Text] [Related]

  • 12. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
    Sahin M, Karatas M, Sahin M, Ertugrul D, Kulaksizoğlu M, Dogruk A, Gokcel A, Tutuncu NB, Guvener ND, Kutlu M.
    Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
    [Abstract] [Full Text] [Related]

  • 13. The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance.
    Xiang GD, Sun HL, Zhao LS, Hou J, Yue L, Xu L.
    Clin Endocrinol (Oxf); 2008 May; 68(5):716-23. PubMed ID: 18070144
    [Abstract] [Full Text] [Related]

  • 14. Excess glycaemic excursions after an oral glucose tolerance test compared with a mixed meal challenge and self-measured home glucose profiles: is the OGTT a valid predictor of postprandial hyperglycaemia and vice versa?
    Meier JJ, Baller B, Menge BA, Gallwitz B, Schmidt WE, Nauck MA.
    Diabetes Obes Metab; 2009 Mar; 11(3):213-22. PubMed ID: 18564177
    [Abstract] [Full Text] [Related]

  • 15. C-peptide pattern in patients with pancreatic cancer.
    Fogar P, Basso D, Panozzo MP, Del Favero G, Briani G, Fabris C, D'Angeli F, Meggiato T, Ferrara C, Plebani M.
    Anticancer Res; 1993 Mar; 13(6B):2577-80. PubMed ID: 8135497
    [Abstract] [Full Text] [Related]

  • 16. Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus.
    Konishi I, Hiasa Y, Shigematsu S, Hirooka M, Furukawa S, Abe M, Matsuura B, Michitaka K, Horiike N, Onji M.
    Liver Int; 2009 Sep; 29(8):1194-201. PubMed ID: 19422477
    [Abstract] [Full Text] [Related]

  • 17. [Behavior of C-peptide and immunoreactive insulin in essential obesity].
    Gragnoli G, Signorini AM, Tanganelli I, Martinelli G.
    Boll Soc Ital Biol Sper; 1979 Mar 30; 55(6):564-70. PubMed ID: 399187
    [Abstract] [Full Text] [Related]

  • 18. Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients.
    Haugaard SB, Andersen O, Hales CN, Halsall I, Rosenfalck AM, Iversen J, Madsbad S.
    Eur J Clin Invest; 2006 Jun 30; 36(6):436-45. PubMed ID: 16684128
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study.
    Mavrogiannaki A, Karamanos B, Manesis EK, Papatheodoridis GV, Koskinas J, Archimandritis AJ.
    J Viral Hepat; 2009 Jun 30; 16(6):430-6. PubMed ID: 19200136
    [Abstract] [Full Text] [Related]

  • 20. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G, Tanganelli I, Signorini AM.
    Boll Soc Ital Biol Sper; 1980 Jan 15; 56(1):69-75. PubMed ID: 7002168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.